Page last updated: 2024-11-02

phenobarbital and Autosomal Dominant Porencephaly Type 1

phenobarbital has been researched along with Autosomal Dominant Porencephaly Type 1 in 1 studies

Phenobarbital: A barbituric acid derivative that acts as a nonselective central nervous system depressant. It potentiates GAMMA-AMINOBUTYRIC ACID action on GABA-A RECEPTORS, and modulates chloride currents through receptor channels. It also inhibits glutamate induced depolarizations.
phenobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and phenyl groups.

Research Excerpts

ExcerptRelevanceReference
"In the three dogs with porencephaly, there was unilateral incomplete loss of the parietal lobe and one dog had additional partial loss of the temporal and frontal lobes."1.38Porencephaly and hydranencephaly in six dogs. ( Behr, S; Davies, ES; de Lahunta, A; Garosi, L; Jull, P; Summers, B; Syme, H; Volk, HA, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Davies, ES1
Volk, HA1
Behr, S1
Summers, B1
de Lahunta, A1
Syme, H1
Jull, P1
Garosi, L1

Other Studies

1 other study available for phenobarbital and Autosomal Dominant Porencephaly Type 1

ArticleYear
Porencephaly and hydranencephaly in six dogs.
    The Veterinary record, 2012, Volume: 170, Issue:7

    Topics: Animals; Cerebellar Diseases; Cerebellum; Dog Diseases; Dogs; Female; Hydranencephaly; Male; Phenoba

2012